{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Parkinson\u2019s disease", "ginseng", "ginsenoside", "neuroprotective effects"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31416121", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "14"}], "Language": ["eng"], "ELocationID": ["2939", "10.3390/molecules24162939"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "16", "PubDate": {"Year": "2019", "Month": "Aug", "Day": "14"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.", "Abstract": {"AbstractText": ["As our global population ages, the treatment of neurodegenerative diseases is critical to our society. In recent years, researchers have begun to study the role of biologically active chemicals from plants and herbs to gain new inspiration and develop new therapeutic drugs. Ginseng (<i>Panax ginseng</i> C.A. Mey.) is a famous Chinese herbal medicine with a variety of pharmacological activities. It has been used to treat various diseases since ancient times. Extensive research over the years has shown that ginseng has potential as a neuroprotective drug, and its neuroprotective effects can be used to treat and prevent neurological damage or pathologically related diseases (such as Alzheimer's disease, Parkinson's disease, Huntington's disease, depression symptoms, and strokes). Moreover, evidence for the medicinal and health benefits of ginsenoside, its main active ingredient, in the prevention of neurodegenerative diseases is increasing, and current clinical results have not reported any serious adverse reactions to ginseng. Therefore, we briefly review the recent research and development on the beneficial effects and mechanisms of ginseng and its main active ingredient, ginsenoside, in the prevention and treatment of neurodegenerative diseases, hoping to provide some ideas for the discovery and identification of ginseng neuroprotection."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China."}], "LastName": "Huang", "ForeName": "Xing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "Research Institute of KPC Pharmaceuticals, Inc., Kunming 650106, China."}], "LastName": "Li", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China."}], "LastName": "Pu", "ForeName": "Yiqiong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. zhangtdmj@hotmail.com."}, {"Identifier": [], "Affiliation": "Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. zhangtdmj@hotmail.com."}], "LastName": "Zhang", "ForeName": "Tong", "Initials": "T"}, {"Identifier": ["0000-0001-9646-0404"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. bwang@simm.ac.cn."}, {"Identifier": [], "Affiliation": "Center for Pharmaceutics Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. bwang@simm.ac.cn."}], "LastName": "Wang", "ForeName": "Bing", "Initials": "B"}], "GrantList": [{"GrantID": "17401902300", "Agency": "Program of Shanghai Committee of Science and Technology", "Country": ""}, {"GrantID": "18XD1403700", "Agency": "Program of Shanghai Academic/Technology Research Leader", "Country": ""}, {"GrantID": "2018FB141", "Agency": "Applied Basic Research Programs of Yunnan Province China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Clinical Studies as Topic"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Liu F.F., Zhang Z., Chen W., Gu H.Y., Yan Q.J. Regulatory mechanism of microRNA-377 on CDH13 expression in the cell model of Alzheimer\u2019s disease. Eur. Rev. Med. Pharmacol. Sci. 2018;22:2801\u20132808.", "ArticleIdList": ["29771432"]}, {"Citation": "Zhong L.L., Song Y.Q., Cao H., Ju K.J., Yu L. The non-motor symptoms of Parkinson\u2019s disease of different motor types in early stage. Eur. Rev. Med Pharmacol. Sci. 2017;21:5745\u20135750.", "ArticleIdList": ["29272011"]}, {"Citation": "Baquero M., Martin N. Depressive symptoms in neurodegenerative diseases. World J. Clin. Cases. 2015;3:682\u2013693. doi: 10.12998/wjcc.v3.i8.682.", "ArticleIdList": ["10.12998/wjcc.v3.i8.682", "PMC4539408", "26301229"]}, {"Citation": "Moon Y., Sung J.H., An R., Hernandez M.E., Sosnoff J.J. Gait variability in people with neurological disorders: A systematic review and meta-analysis. Hum. Mov. Sci. 2016;47:197\u2013208. doi: 10.1016/j.humov.2016.03.010.", "ArticleIdList": ["10.1016/j.humov.2016.03.010", "27023045"]}, {"Citation": "Buendia I., Michalska P., Navarro E., Gameiro I., Egea J., Le\u00f3n R. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol. Ther. 2016;157:84\u2013104. doi: 10.1016/j.pharmthera.2015.11.003.", "ArticleIdList": ["10.1016/j.pharmthera.2015.11.003", "26617217"]}, {"Citation": "Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.", "ArticleIdList": ["10.1038/emm.2014.117", "PMC4351408", "25766616"]}, {"Citation": "Kang S., Im K., Kim G., Min H. Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus. J. Ginseng Res. 2017;41:496\u2013502. doi: 10.1016/j.jgr.2016.08.010.", "ArticleIdList": ["10.1016/j.jgr.2016.08.010", "PMC5628367", "29021696"]}, {"Citation": "Hong B.N., Ji M.G., Kang T.H. The Efficacy of Red Ginseng in Type 1 and Type 2 Diabetes in Animals. Evid. Based Complement. Altern. Med. 2013;2013:593181. doi: 10.1155/2013/593181.", "ArticleIdList": ["10.1155/2013/593181", "PMC3844252", "24319479"]}, {"Citation": "Jeong C.S. Effect of butanol fraction of Panax ginseng head on gastric lesion and ulcer. Arch. Pharmacal. Res. 2002;25:61. doi: 10.1007/BF02975263.", "ArticleIdList": ["10.1007/BF02975263", "11885694"]}, {"Citation": "Kiefer D., Pantuso T. Panax ginseng. Am. Fam. Physician. 2003;68:1539\u20131542.", "ArticleIdList": ["14596440"]}, {"Citation": "Liu X., Wang L., Wen A., Yang J., Yan Y., Song Y., Liu X., Ren H., Wu Y., Li Z., et al. Ginsenoside-Rd improves outcome of acute ischaemic stroke\u2014A randomized, double-blind, placebo-controlled, multicenter trial. Eur. J. Neurol. 2012;19:855\u2013863. doi: 10.1111/j.1468-1331.2011.03634.x.", "ArticleIdList": ["10.1111/j.1468-1331.2011.03634.x", "22233205"]}, {"Citation": "Strong M.J., Grace G.M., Freedman M., Lomen-Hoerth C., Woolley S., Goldstein L.H., Murphy J., Shoesmith C., Rosenfeld J., Leigh P.N. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Mot. Neuron Disord. 2009;10:131\u2013146. doi: 10.1080/17482960802654364.", "ArticleIdList": ["10.1080/17482960802654364", "19462523"]}, {"Citation": "Wang L., Zhang Y., Wang Z., Li S., Min G., Wang L., Chen J., Cheng J., Wu Y. Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats. Can. J. Physiol. Pharmacol. 2012;90:229\u2013236. doi: 10.1139/y11-127.", "ArticleIdList": ["10.1139/y11-127", "22300288"]}, {"Citation": "Yang X.L., Guo T.K., Wang Y.H., Huang Y.H., Liu X., Wang X.X., Li W., Zhao X., Wang L.P., Yan S. Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis. Int. Immunopharmacol. 2012;12:408\u2013414. doi: 10.1016/j.intimp.2011.12.014.", "ArticleIdList": ["10.1016/j.intimp.2011.12.014", "22227208"]}, {"Citation": "Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 1999;58:1685\u20131693. doi: 10.1016/S0006-2952(99)00212-9.", "ArticleIdList": ["10.1016/S0006-2952(99)00212-9", "10571242"]}, {"Citation": "Gillis C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol. 1997;54:1\u20138. doi: 10.1016/S0006-2952(97)00193-7.", "ArticleIdList": ["10.1016/S0006-2952(97)00193-7", "9296344"]}, {"Citation": "Pe\u00f1a I.D., Yoon S.Y., Kim H.J., Park S., Hong E.Y., Ryu J.H., Park I.H., Cheong J.H. Effects of ginseol k-g3, an Rg3-enriched fraction, on scopolamine-induced memory impairment and learning deficit in mice. J. Ginseng Res. 2014;38:1\u20137. doi: 10.1016/j.jgr.2013.11.003.", "ArticleIdList": ["10.1016/j.jgr.2013.11.003", "PMC3915335", "24558303"]}, {"Citation": "Christensen L.P. Chapter 1 Ginsenosides: Chemistry, Biosynthesis, Analysis, and Potential Health Effects. Adv. Food Nutr. Res. 2008;55:1\u201399.", "ArticleIdList": ["18772102"]}, {"Citation": "Shin B.K., Kwon S.W., Park J.H. Chemical diversity of ginseng saponins from Panax ginseng. J. Ginseng Res. 2015;39:287\u2013298. doi: 10.1016/j.jgr.2014.12.005.", "ArticleIdList": ["10.1016/j.jgr.2014.12.005", "PMC4593792", "26869820"]}, {"Citation": "Mancuso C., Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem. Toxicol. 2017;107:362\u2013372. doi: 10.1016/j.fct.2017.07.019.", "ArticleIdList": ["10.1016/j.fct.2017.07.019", "PMC7116968", "28698154"]}, {"Citation": "Kim J.S., Kim Y., Han S.H., Jeon J.Y., Hwang M., Im Y.J., Kim J.H., Sun Y.L., Chae S.W., Kim M.G. Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application. J. Ginseng Res. 2013;37:135\u2013141. doi: 10.5142/jgr.2013.37.135.", "ArticleIdList": ["10.5142/jgr.2013.37.135", "PMC3659617", "23717167"]}, {"Citation": "Koh E., Jang O.H., Hwang K.H., An Y.N., Moon B.K. Effects of Steaming and Air-Drying on Ginsenoside Composition of Korean Ginseng (Panax ginseng C.A. Meyer) J. Food Process. Preserv. 2015;39:207\u2013213. doi: 10.1111/jfpp.12412.", "ArticleIdList": ["10.1111/jfpp.12412"]}, {"Citation": "Sun Y., Yue L., Chen K. Roles and mechanisms of ginsenoside in cardiovascular diseases: Progress and perspectives. Sci. China Life Sci. 2016;59:292\u2013298. doi: 10.1007/s11427-016-5007-8.", "ArticleIdList": ["10.1007/s11427-016-5007-8", "26798041"]}, {"Citation": "Wang Y., Huang C., Zhang H., Wu R. Autophagy in glaucoma: Crosstalk with apoptosis and its implications. Brain Res. Bull. 2015;117:1\u20139. doi: 10.1016/j.brainresbull.2015.06.001.", "ArticleIdList": ["10.1016/j.brainresbull.2015.06.001", "26073842"]}, {"Citation": "Lee B., Sandhu S., McArthur G. Cell cycle control as a promising target in melanoma. Curr. Opin. Oncol. 2015;27:141\u2013150. doi: 10.1097/CCO.0000000000000159.", "ArticleIdList": ["10.1097/CCO.0000000000000159", "25588041"]}, {"Citation": "Brassai A., Suvanjeiev R.G., Ban E.G., Lakatos M. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res. Bull. 2015;112:1\u20136. doi: 10.1016/j.brainresbull.2014.12.007.", "ArticleIdList": ["10.1016/j.brainresbull.2014.12.007", "25540918"]}, {"Citation": "Dong X., Zheng L., Lu S., Yang Y. Neuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia-induced injuries in aged mice: Involvement of anti-oxidant signaling. Geriatr. Gerontol. Int. 2017;17:338\u2013345. doi: 10.1111/ggi.12699.", "ArticleIdList": ["10.1111/ggi.12699", "26712031"]}, {"Citation": "Lv H., Wang L., Shen J., Hao S., Ming A., Wang X., Su F., Zhang Z. Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats. Brain Res. Bull. 2015;115:30\u201336. doi: 10.1016/j.brainresbull.2015.05.002.", "ArticleIdList": ["10.1016/j.brainresbull.2015.05.002", "25981395"]}, {"Citation": "Liu C.X., Xiao P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 1992;36:27\u201338.", "ArticleIdList": ["1501490"]}, {"Citation": "Nah S.Y., Park H.J., Mccleskey E.W. A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein. Proc. Natl. Acad. Sci. USA. 1995;92:8739\u20138743. doi: 10.1073/pnas.92.19.8739.", "ArticleIdList": ["10.1073/pnas.92.19.8739", "PMC41042", "7568008"]}, {"Citation": "Nocerino E., Amato M., Izzo A.A. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia. 2000;71:S1\u2013S5. doi: 10.1016/S0367-326X(00)00170-2.", "ArticleIdList": ["10.1016/S0367-326X(00)00170-2", "10930706"]}, {"Citation": "Van J.K., Robertson H., Hagg T., Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson\u2019s disease. Exp. Neurol. 2003;184:521\u2013529.", "ArticleIdList": ["14637121"]}, {"Citation": "Liu L., Anderson G.A., Fernandez T.G., Dore S. Efficacy and Mechanism of Panax Ginseng in Experimental Stroke. Front. Neurosci. 2019;13:294. doi: 10.3389/fnins.2019.00294.", "ArticleIdList": ["10.3389/fnins.2019.00294", "PMC6491687", "31068769"]}, {"Citation": "Gonzalez-Burgos E., Fernandez-Moriano C., Gomez-Serranillos M.P. Potential neuroprotective activity of Ginseng in Parkinson\u2019s disease: A review. J. Neuroimmune Pharmacol. 2015;10:14\u201329. doi: 10.1007/s11481-014-9569-6.", "ArticleIdList": ["10.1007/s11481-014-9569-6", "25349145"]}, {"Citation": "Razgonova M.P., Veselov V.V., Zakharenko A.M., Golokhvast K.S., Nosyrev A.E., Cravotto G., Tsatsakis A., Spandidos D.A. Panax ginseng components and the pathogenesis of Alzheimer\u2019s disease (Review) Mol. Med. Rep. 2019;19:2975\u20132998. doi: 10.3892/mmr.2019.9972.", "ArticleIdList": ["10.3892/mmr.2019.9972", "PMC6423617", "30816465"]}, {"Citation": "Kim K.H., Lee D., Lee H.L., Kim C.E., Jung K., Kang K.S. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions. J. Ginseng Res. 2018;42:239\u2013247. doi: 10.1016/j.jgr.2017.03.011.", "ArticleIdList": ["10.1016/j.jgr.2017.03.011", "PMC6035378", "29989012"]}, {"Citation": "Rajabian A., Rameshrad M., Hosseinzadeh H. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: A patent review. Expert Opin. Ther. Pat. 2018;29:55\u201372. doi: 10.1080/13543776.2019.1556258.", "ArticleIdList": ["10.1080/13543776.2019.1556258", "30513224"]}, {"Citation": "Mattson M.P. Oxidative Stress, Perturbed Calcium Homeostasis, and Immune Dysfunction in Alzheimer\u2019s Disease. J. NeuroVirol. 2002;8:539\u2013550. doi: 10.1080/13550280290100978.", "ArticleIdList": ["10.1080/13550280290100978", "12476348"]}, {"Citation": "Harrop J.S., Sharan A.D., Vaccaro A.R., Przybylski G.J. The cause of neurologic deterioration after acute cervical spinal cord injury. Spine. 2001;26:340\u2013346. doi: 10.1097/00007632-200102150-00008.", "ArticleIdList": ["10.1097/00007632-200102150-00008", "11224879"]}, {"Citation": "Appel S.H., Smith R.G., Le W.D. Immune-mediated cell death in neurodegenerative disease. Adv. Neurol. 1996;69:153\u2013159.", "ArticleIdList": ["8615124"]}, {"Citation": "Hardy J. Pathways to Primary Neurodegenerative Disease. Ann. N. Y. Acad. Sci. 2000;924:29\u201334. doi: 10.1111/j.1749-6632.2000.tb05556.x.", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb05556.x", "11193798"]}, {"Citation": "Braak H., Tredici K.D., R\u00fcb U., Vos R.A.I.D., Steur E.N.H.J., Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging. 2003;24:197\u2013211. doi: 10.1016/S0197-4580(02)00065-9.", "ArticleIdList": ["10.1016/S0197-4580(02)00065-9", "12498954"]}, {"Citation": "Hebert L.E., Jennifer W., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology. 2013;80:1778\u20131783. doi: 10.1212/WNL.0b013e31828726f5.", "ArticleIdList": ["10.1212/WNL.0b013e31828726f5", "PMC3719424", "23390181"]}, {"Citation": "Bolognin S., Blanchard J., Wang X., Basurtoislas G., Tung Y.C., Kohlbrenner E., Grundkeiqbal I., Iqbal K. An experimental rat model of sporadic Alzheimer\u2019s disease and rescue of cognitive impairment with a neurotrophic peptide. Acta Neuropathol. 2012;123:133\u2013151. doi: 10.1007/s00401-011-0908-x.", "ArticleIdList": ["10.1007/s00401-011-0908-x", "PMC3889170", "22083255"]}, {"Citation": "Pratic\u00f2 D. Oxidative stress hypothesis in Alzheimer\u2019s disease: A reappraisal. Trends Pharmacol. Sci. 2008;29:609\u2013615. doi: 10.1016/j.tips.2008.09.001.", "ArticleIdList": ["10.1016/j.tips.2008.09.001", "18838179"]}, {"Citation": "Li N., Liu Y., Li W., Zhou L., Li Q., Wang X., He P. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer\u2019s disease. J. Ginseng Res. 2016;40:9\u201317. doi: 10.1016/j.jgr.2015.04.006.", "ArticleIdList": ["10.1016/j.jgr.2015.04.006", "PMC4703800", "26843817"]}, {"Citation": "Li N., Liu B., Dluzen D.E., Jin Y. Protective effects of ginsenoside Rg 2 against glutamate-induced neurotoxicity in PC12 cells. J. Ethnopharmacol. 2007;111:458\u2013463. doi: 10.1016/j.jep.2006.12.015.", "ArticleIdList": ["10.1016/j.jep.2006.12.015", "17257792"]}, {"Citation": "Liu L., Huang J., Hu X., Li K., Sun C. Simultaneous determination of ginsenoside (G-Re, G-Rg1, G-Rg2, G-F1, G-Rh1) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011;879:2011\u20132017. doi: 10.1016/j.jchromb.2011.05.018.", "ArticleIdList": ["10.1016/j.jchromb.2011.05.018", "21704572"]}, {"Citation": "Jun Y.E., Yao J.P., Wang X.U., Zheng M., Peng L.I., Chengwei H.E., Wan J.B., Yao X., Huanxing S.U. Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury. Mol. Med. Rep. 2016;13:3083\u20133091.", "ArticleIdList": ["PMC4805061", "26935530"]}, {"Citation": "Peng L.H., Ko C.H., Siu S.W., Koon C.M., Yue G.L., Cheng W.H., Lau T.W., Han Q.B., Ng K.M., Fung K.P., et al. In vitro & in vivo assessment of a herbal formula used topically for bone fracture treatment. J. Ethnopharmacol. 2010;131:282\u2013289.", "ArticleIdList": ["20600749"]}, {"Citation": "Fang F., Chen X., Huang T., Lue L.F., Luddy J.S., Yan S.S. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim. Biophys. Acta. 2012;1822:286\u2013292. doi: 10.1016/j.bbadis.2011.10.004.", "ArticleIdList": ["10.1016/j.bbadis.2011.10.004", "PMC3304026", "22015470"]}, {"Citation": "Chen X.M. Effect of Dosage Form and Administration Route to Distribution of Ginsenoside Rg1 in Serum and Brain of Rats. Chin. J. Exp. Tradit. Med Formulae. 2011;17:43\u201346."}, {"Citation": "Bai-Yin H., Chang-Qing L., You-Liang X., Dong-Xu J., Jian-Nan C., Fang-Yi L. Study on percutaneous absorption of ginsenoside Rg1 in total saponins from Panax notoginseng through intact skin. J. Guangdong Pharm. Coll. 2010;26:564\u2013567."}, {"Citation": "Jia L., Wei C., Zi-Min Y., Xue-Tao L. In vitro transdermal absorption studies of ginsenoside Rg1 in traumatology spray. Chin. J. Exp. Tradit. Chin. Med. 2010;18:18\u201320."}, {"Citation": "Yuan S., Bo L., Xiu-Mei T. Experimental study on in vitro permeation of swollen and painful cataplasm. Yunnan J. Tradit. Chin. Med. 2012;33:54."}, {"Citation": "Hong-Cai W., Yu-Meng J., Xue Z., Ning W., Di G., Ming G., Jing-Yu Z., Zi-Chao Y. Protective effects of ginsenoside Rb1 on A\u03b2 amyloid-induced hippocampal neuronal injury in rats. J. Jilin Univ. Med. Ed. 2012;38:447\u2013450."}, {"Citation": "Zhao H.H., Di J., Liu W.S., Liu H.L., Lai H., Lu Y.L. Involvement of GSK3 and PP2A in ginsenoside Rb1\u2032s attenuation of aluminum-induced tau hyperphosphorylation. Behav. Brain Res. 2013;241:228\u2013234. doi: 10.1016/j.bbr.2012.11.037.", "ArticleIdList": ["10.1016/j.bbr.2012.11.037", "23219964"]}, {"Citation": "Schapira A.H. Pathogenesis of Parkinson\u2019s disease. Bailli\u00e8res Clin. Neurol. 2011;258:307\u2013310.", "ArticleIdList": ["9426866"]}, {"Citation": "Lees A.J., Hardy J., Revesz T. Parkinson\u2019s disease. Lancet. 2009;373:2055\u20132066. doi: 10.1016/S0140-6736(09)60492-X.", "ArticleIdList": ["10.1016/S0140-6736(09)60492-X", "19524782"]}, {"Citation": "Badger J.L., Corderollana O., Hartfield E.M., Wademartins R. Parkinson\u2019s disease in a dish\u2014Using stem cells as a molecular tool. Neuropharmacology. 2014;76:88\u201396. doi: 10.1016/j.neuropharm.2013.08.035.", "ArticleIdList": ["10.1016/j.neuropharm.2013.08.035", "24035919"]}, {"Citation": "Kim D., Jeon H., Ryu S., Koo S., Ha K.T., Kim S. Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson\u2019s Disease Mouse Model. PLoS ONE. 2016;11:e0164906. doi: 10.1371/journal.pone.0164906.", "ArticleIdList": ["10.1371/journal.pone.0164906", "PMC5082921", "27788166"]}, {"Citation": "Zhou T., Zu G., Zhang X., Wang X., Li S., Gong X., Liang Z., Zhao J. Neuroprotective effects of ginsenoside Rg1 through the Wnt/beta-catenin signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease. Neuropharmacology. 2016;101:480\u2013489. doi: 10.1016/j.neuropharm.2015.10.024.", "ArticleIdList": ["10.1016/j.neuropharm.2015.10.024", "26525190"]}, {"Citation": "Ardah M.T., Paleologou K.E., Lv G., Menon S.A., Abul Khair S.B., Lu J.H., Safieh-Garabedian B., Al-Hayani A.A., Eliezer D., Li M., et al. Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiol. Dis. 2015;74:89\u2013101. doi: 10.1016/j.nbd.2014.11.007.", "ArticleIdList": ["10.1016/j.nbd.2014.11.007", "PMC4882765", "25449909"]}, {"Citation": "Radad K., Gille G., Moldzio R., Saito H., Ishige K., Rausch W.D. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells. J. Neural Transm. 2004;111:37\u201345. doi: 10.1007/s00702-003-0063-1.", "ArticleIdList": ["10.1007/s00702-003-0063-1", "14714214"]}, {"Citation": "Heng Y., Zhang Q.S., Mu Z., Hu J.F., Yuan Y.H., Chen N.H. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting alpha-synuclein abnormalities in the substantia nigra. Toxicol. Lett. 2016;243:7\u201321. doi: 10.1016/j.toxlet.2015.12.005.", "ArticleIdList": ["10.1016/j.toxlet.2015.12.005", "26723869"]}, {"Citation": "Zhou T.T., Zu G., Wang X., Zhang X.G., Li S., Liang Z.H., Zhao J. Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson\u2019s disease. Int. Immunopharmacol. 2015;29:334\u2013343. doi: 10.1016/j.intimp.2015.10.032.", "ArticleIdList": ["10.1016/j.intimp.2015.10.032", "26548343"]}, {"Citation": "Chen C., Wang L., Cao F., Miao X., Chen T., Chang Q., Zheng Y. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery. Int. J. Pharm. 2016;497:239\u2013247. doi: 10.1016/j.ijpharm.2015.12.014.", "ArticleIdList": ["10.1016/j.ijpharm.2015.12.014", "26680316"]}, {"Citation": "Sun X.C., Ren X.F., Chen L., Gao X.Q., Xie J.X., Chen W.F. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. J. Steroid Biochem. Mol. Biol. 2016;155:94\u2013103. doi: 10.1016/j.jsbmb.2015.09.040.", "ArticleIdList": ["10.1016/j.jsbmb.2015.09.040", "26455404"]}, {"Citation": "Khadrawy Y.A., Mourad I.M., Mohammed H.S., Noor N.A., Ezz H.S.A. A study on the possible therapeutic role of Panax ginseng extract against a rat model of Parkinson\u2019s disease induced by intrastriatal rotenone injection. Int. J. Clin. Exp. Med. 2016;9:3831\u20133841."}, {"Citation": "Chen X., Huang T., Zhang J., Song J., Chen L., Zhu Y. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1\u2032s attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons. Brain Res. 2008;1200:99\u2013106. doi: 10.1016/j.brainres.2007.12.029.", "ArticleIdList": ["10.1016/j.brainres.2007.12.029", "18289510"]}, {"Citation": "Chong M.S., Goh L.K., Lim W.S., Chan M., Tay L., Chen G., Feng L., Ng T.P., Tan C.H., Lee T.S. Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. JAD. 2013;34:399\u2013405. doi: 10.3233/JAD-121621.", "ArticleIdList": ["10.3233/JAD-121621", "23234877"]}, {"Citation": "Hwang J.Y., Shim J.S., Song M.Y., Yim S.V., Lee S.E., Park K.S. Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in beta-amyloid-treated neuronal cells. J. Ginseng Res. 2016;40:278\u2013284. doi: 10.1016/j.jgr.2015.09.004.", "ArticleIdList": ["10.1016/j.jgr.2015.09.004", "PMC5005364", "27616904"]}, {"Citation": "Zhao H., Li Q., Zhang Z., Pei X., Wang J., Li Y. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res. 2009;1256:111\u2013122. doi: 10.1016/j.brainres.2008.12.031.", "ArticleIdList": ["10.1016/j.brainres.2008.12.031", "19133247"]}, {"Citation": "Baake V., Reijntjes R., Dumas E.M., Thompson J.C., Roos R.A.C., REGISTRY Investigators of the European Huntington\u2019s Disease Network Cognitive decline in Huntington\u2019s disease expansion gene carriers. Cortex. 2017;95:51\u201362. doi: 10.1016/j.cortex.2017.07.017.", "ArticleIdList": ["10.1016/j.cortex.2017.07.017", "28843844"]}, {"Citation": "Mehrabi N.F., Waldvogel H.J., Tippett L.J., Hogg V.M., Synek B.J., Faull R.L. Symptom heterogeneity in Huntington\u2019s disease correlates with neuronal degeneration in the cerebral cortex. Neurobiol. Dis. 2016;96:67\u201374. doi: 10.1016/j.nbd.2016.08.015.", "ArticleIdList": ["10.1016/j.nbd.2016.08.015", "27569581"]}, {"Citation": "Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Hevelone N., Hersch S.M. Complexity and Heterogeneity: What Drives the Ever-changing Brain in Huntington\u2019s Disease? Ann. N. Y. Acad. Sci. 2008;1147:196\u2013205. doi: 10.1196/annals.1427.034.", "ArticleIdList": ["10.1196/annals.1427.034", "PMC2813569", "19076442"]}, {"Citation": "Waldvogel H.J., Thu D., Hogg V., Tippett L., Faull R.L.M. Selective neurodegeneration, neuropathology and symptom profiles in Huntington\u2019s disease. Adv. Exp. Med. Biol. 2012;769:141\u2013152.", "ArticleIdList": ["23560309"]}, {"Citation": "Wu J., Jeong H.K., Bulin S.E., Kwon S.W., Park J.H., Bezprozvanny I. Ginsenosides protect striatal neurons in a cellular model of Huntington\u2019s disease. J. Neurosci. Res. 2009;87:1904\u20131912. doi: 10.1002/jnr.22017.", "ArticleIdList": ["10.1002/jnr.22017", "PMC2792727", "19185022"]}, {"Citation": "Kim J.H., Kim S., Yoon I.S., Lee J.H., Jang B.J., Jeong S.M., Lee J.H., Lee B.H., Han J.S., Oh S., et al. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology. 2005;48:743\u2013756. doi: 10.1016/j.neuropharm.2004.12.013.", "ArticleIdList": ["10.1016/j.neuropharm.2004.12.013", "15814108"]}, {"Citation": "Johnston S.C., Mendis S., Mathers C.D. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8:345\u2013354. doi: 10.1016/S1474-4422(09)70023-7.", "ArticleIdList": ["10.1016/S1474-4422(09)70023-7", "19233730"]}, {"Citation": "Woodruff T.M., Thundyil J., Tang S.C., Sobey C.G., Taylor S.M., Arumugam T.V. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol. Neurodegener. 2011;6:11. doi: 10.1186/1750-1326-6-11.", "ArticleIdList": ["10.1186/1750-1326-6-11", "PMC3037909", "21266064"]}, {"Citation": "Gomes J., Wachsman A.M. Handbook of Clinical Nutrition and Stroke. Humana Press; Totowa, NJ, USA: 2013. Types of Strokes; pp. 15\u201331."}, {"Citation": "Callahan A., Amarenco P., Goldstein L.B., Sillesen H., Messig M., Samsa G.P., Altafullah I., Ledbetter L.Y., Macleod M.J., Scott R. Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Arch. Neurol. 2011;68:1245\u20131251. doi: 10.1001/archneurol.2011.146.", "ArticleIdList": ["10.1001/archneurol.2011.146", "21670382"]}, {"Citation": "Zheng G.Q., Cheng W., Wang Y., Wang X.M., Zhao S.Z., Zhou Y., Liu S.J., Wang X.T. Ginseng total saponins enhance neurogenesis after focal cerebral ischemia. J. Ethnopharmacol. 2011;133:724\u2013728. doi: 10.1016/j.jep.2010.01.064.", "ArticleIdList": ["10.1016/j.jep.2010.01.064", "21073942"]}, {"Citation": "Liu X., Xia J., Wang L., Song Y., Yang J., Yan Y., Ren H., Zhao G. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: A randomized, double-blind, placebo-controlled, phase II multicenter trial. Eur. J. Neurol. 2009;16:569\u2013575. doi: 10.1111/j.1468-1331.2009.02534.x.", "ArticleIdList": ["10.1111/j.1468-1331.2009.02534.x", "19236467"]}, {"Citation": "Sutherland B.A., Minnerup J., Balami J.S., Arba F., Buchan A.M., Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. Int. J. Stroke. 2012;7:407\u2013418. doi: 10.1111/j.1747-4949.2012.00770.x.", "ArticleIdList": ["10.1111/j.1747-4949.2012.00770.x", "22394615"]}, {"Citation": "Wahlgren N.G., Ahmed N. Neuroprotection in cerebral ischaemia: Facts and fancies\u2014the need for new approaches. Cerebrovasc. Dis. 2004;17:153\u2013166. doi: 10.1159/000074808.", "ArticleIdList": ["10.1159/000074808", "14694293"]}, {"Citation": "Yoshikawa T., Akiyoshi Y., Susumu T., Tokado H., Fukuzaki K., Nagata R., Samukawa K., Iwao H., Kito G. Ginsenoside Rb1 Reduces Neurodegeneration in the Peri-infarct Area of a Thromboembolic Stroke Model in Non-human Primates. J. Pharmacol. Sci. 2008;107:32\u201340. doi: 10.1254/jphs.FP0071297.", "ArticleIdList": ["10.1254/jphs.FP0071297", "18446006"]}, {"Citation": "Li Y., Tang J., Khatibi N.H., Zhu M., Chen D., Tu L., Chen L., Wang S. Treatment with ginsenoside rb1, a component of panax ginseng, provides neuroprotection in rats subjected to subarachnoid hemorrhage-induced brain injury. Acta Neurochir. Suppl. 2011;110:75\u201379.", "ArticleIdList": ["21125449"]}, {"Citation": "Jiang Z., Wang Y., Zhang X., Peng T., Lu Y., Leng J., Xie Q. Preventive and therapeutic effects of ginsenoside Rb1 for neural injury during cerebral infarction in rats. Am. J. Chin. Med. 2013;41:341\u2013352. doi: 10.1142/S0192415X13500250.", "ArticleIdList": ["10.1142/S0192415X13500250", "23548124"]}, {"Citation": "Wan F., Si Y.C., Niu X. Effects of astrocyte following treatment with ginsenoside on proliferation and differentiation of neural stem cells after stroke. China J. Tradit. Chin. Med. Pharm. 2016;5:1617\u20131624."}, {"Citation": "Chen J., Bai Q., Zhao Z., Sui H., Xie X. Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-beta1. J. Stroke Cerebrovasc. Dis. 2016;25:549\u2013555. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.004.", "ArticleIdList": ["10.1016/j.jstrokecerebrovasdis.2015.11.004", "26683593"]}, {"Citation": "Tuttolomondo A., Sciacca R.D., Raimondo D.D., Pedone C., Placa S.L., Pinto A., Licata G. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: A retrospective chart review from the GIFA study. Int. J. Cardiol. 2011;151:318\u2013322. doi: 10.1016/j.ijcard.2010.06.005.", "ArticleIdList": ["10.1016/j.ijcard.2010.06.005", "20598761"]}, {"Citation": "Guo Z., Cao G., Yang H., Zhou H., Li L., Cao Z., Yu B., Kou J. A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways. J. Neurosci. Res. 2014;92:1295\u20131306. doi: 10.1002/jnr.23400.", "ArticleIdList": ["10.1002/jnr.23400", "24801159"]}, {"Citation": "Gao X.Q., Yang C.X., Chen G.J., Wang G.Y., Chen B., Tan S.K., Liu J., Yuan Q.L. Ginsenoside Rb1 regulates the expressions of brain-derived neurotrophic factor and caspase-3 and induces neurogenesis in rats with experimental cerebral ischemia. J. Ethnopharmacol. 2010;132:393\u2013399. doi: 10.1016/j.jep.2010.07.033.", "ArticleIdList": ["10.1016/j.jep.2010.07.033", "20659542"]}, {"Citation": "Rui W., Li Y.N., Wang G.J., Hao H.P., Wu X.L., Fang Z. Neuroprotective effects and brain transport of ginsenoside Rg1. Chin. J. Nat. Med. 2009;7:315\u2013320."}, {"Citation": "Sierra C., Coca A., Schiffrin E.L. Vascular mechanisms in the pathogenesis of stroke. Curr. Hypertens. Rep. 2011;13:200\u2013207. doi: 10.1007/s11906-011-0195-x.", "ArticleIdList": ["10.1007/s11906-011-0195-x", "21331606"]}, {"Citation": "Allen C.L., Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke. 2009;4:461\u2013470. doi: 10.1111/j.1747-4949.2009.00387.x.", "ArticleIdList": ["10.1111/j.1747-4949.2009.00387.x", "19930058"]}, {"Citation": "Kim J.S., Yun I., Choi Y.B., Lee K.S., Kim Y.I. Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat. J. Clin. Neurosci. 2008;15:174\u2013178. doi: 10.1016/j.jocn.2006.12.003.", "ArticleIdList": ["10.1016/j.jocn.2006.12.003", "17997315"]}, {"Citation": "Sun Z.G., Chen L.P., Wang F.W., Xu C.Y., Geng M. Protective effects of ginsenoside Rg1 against hydrogen peroxide-induced injur y in human neuroblastoma cells. Neural Regen. Res. 2016;11:1159\u20131164.", "ArticleIdList": ["PMC4994462", "27630703"]}, {"Citation": "Xie Z., Shi M., Zhang C., Zhao H., Hui H., Zhao G. Ginsenoside Rd Protects Against Cerebral Ischemia-Reperfusion Injury Via Decreasing the Expression of the NMDA Receptor 2B Subunit and its Phosphorylated Product. Neurochem. Res. 2016;41:2149\u20132159. doi: 10.1007/s11064-016-1930-0.", "ArticleIdList": ["10.1007/s11064-016-1930-0", "27165636"]}, {"Citation": "Xie C.L., Li J.H., Wang W.W., Zheng G.Q., Wang L.X. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression. Life Sci. 2015;121:145\u2013151. doi: 10.1016/j.lfs.2014.12.002.", "ArticleIdList": ["10.1016/j.lfs.2014.12.002", "25498890"]}, {"Citation": "Zhang Y.F., Fan X.J., Li X., Peng L.L., Wang G.H., Ke K.F., Jiang Z.L. Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels. Eur. J. Pharmacol. 2008;586:90\u201399. doi: 10.1016/j.ejphar.2007.12.037.", "ArticleIdList": ["10.1016/j.ejphar.2007.12.037", "18430419"]}, {"Citation": "Ye R., Kong X., Yang Q., Zhang Y., Han J., Li P., Xiong L., Zhao G. Ginsenoside rd in experimental stroke: Superior neuroprotective efficacy with a wide therapeutic window. Neurotherapeutics. 2011;8:515\u2013525. doi: 10.1007/s13311-011-0051-3.", "ArticleIdList": ["10.1007/s13311-011-0051-3", "PMC3250281", "21647765"]}, {"Citation": "Ye R., Kong X., Yang Q., Zhang Y., Han J., Zhao G. Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology. 2011;61:815\u2013824. doi: 10.1016/j.neuropharm.2011.05.029.", "ArticleIdList": ["10.1016/j.neuropharm.2011.05.029", "21664366"]}, {"Citation": "Ye R., Zhang X., Kong X., Han J., Yang Q., Zhang Y., Chen Y., Li P., Liu J., Shi M., et al. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience. 2011;178:169\u2013180. doi: 10.1016/j.neuroscience.2011.01.007.", "ArticleIdList": ["10.1016/j.neuroscience.2011.01.007", "21219973"]}, {"Citation": "Ye R., Yang Q., Kong X., Han J., Zhang X., Zhang Y., Li P., Liu J., Shi M., Xiong L., et al. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem. Int. 2011;58:391\u2013398. doi: 10.1016/j.neuint.2010.12.015.", "ArticleIdList": ["10.1016/j.neuint.2010.12.015", "21185898"]}, {"Citation": "Ye R., Li N., Han J., Kong X., Cao R., Rao Z., Zhao G. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci. Res. 2009;64:306\u2013310. doi: 10.1016/j.neures.2009.03.016.", "ArticleIdList": ["10.1016/j.neures.2009.03.016", "19447300"]}, {"Citation": "Strunk D.R., Adler A.D., Hollars S.N. Cognitive Therapy Skills Predict Cognitive Reactivity to Sad Mood Following Cognitive Therapy of Depression. Cognitive Ther. Res. 2013;37:1214\u20131219. doi: 10.1007/s10608-013-9570-z.", "ArticleIdList": ["10.1007/s10608-013-9570-z", "PMC3867014", "24363473"]}, {"Citation": "Harzheim D., Klose H., Pinado F.P., Ehlken N., Nagel C., Fischer C., Ghofrani A., Rosenkranz S., Seyfarth H.J., Halank M. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir. Res. 2013;14:104. doi: 10.1186/1465-9921-14-104.", "ArticleIdList": ["10.1186/1465-9921-14-104", "PMC4021210", "24107187"]}, {"Citation": "Jin C., Wang Z.Z., Zhou H., Lou Y.X., Chen J., Zuo W., Tian M.T., Wang Z.Q., Du G.H., Kawahata I., et al. Ginsenoside Rg1-induced antidepressant effects involve the protection of astrocyte gap junctions within the prefrontal cortex. Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2017;75:183\u2013191. doi: 10.1016/j.pnpbp.2016.09.006.", "ArticleIdList": ["10.1016/j.pnpbp.2016.09.006", "27876669"]}, {"Citation": "Jeong H.G., Ko Y.H., Oh S.Y., Han C., Kim T., Joe S.H. Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression. Asia Pac. Psychiatry. 2015;7:330\u2013336. doi: 10.1111/appy.12169.", "ArticleIdList": ["10.1111/appy.12169", "25504813"]}, {"Citation": "Lee K.J., Ji G.E. The effect of fermented red ginseng on depression is mediated by lipids. Nutr. Neurosci. 2014;17:7\u201315. doi: 10.1179/1476830513Y.0000000059.", "ArticleIdList": ["10.1179/1476830513Y.0000000059", "24088416"]}, {"Citation": "Kim M., Kim S.O., Lee M., Park Y., Kim D., Cho K.H., Kim S.Y., Lee E.H. Effects of ginsenoside Rb1 on the stress-induced changes of BDNF and HSP70 expression in rat hippocampus. Environ. Toxicol. Pharmacol. 2014;38:257\u2013262. doi: 10.1016/j.etap.2014.06.004.", "ArticleIdList": ["10.1016/j.etap.2014.06.004", "24975446"]}, {"Citation": "Sang H.L., Jung B.H., Sang Y.C., Sun Y.K., Lee E.H., Chung B.C. Influence of ginsenoside Rb1 on brain neurosteroid during acute immobilization stress. Arch. Pharmacal. Res. 2006;29:566\u2013569.", "ArticleIdList": ["16903076"]}, {"Citation": "Lee S.H., Jung B.H., Kim S.Y., Lee E.H., Chung B.C. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol. Res. 2006;54:46\u201349. doi: 10.1016/j.phrs.2006.02.001.", "ArticleIdList": ["10.1016/j.phrs.2006.02.001", "16530422"]}, {"Citation": "Sang H.L., Hur J., Lee E.H., Sun Y.K. Ginsenoside Rb1 Modulates Level of Monoamine Neurotransmitters in Mice Frontal Cortex and Cerebellum in Response to Immobilization Stress. Biomol. Ther. 2012;20:482\u2013486.", "ArticleIdList": ["PMC3762281", "24009838"]}, {"Citation": "Jia D.Y., Zhang M.X., Yao Y.R., Jin W., Liu J.W., Wang J.L., Chen B.C. Effects of ginsenoside Rb1 on the mRNA expression of tyrosine kinase B in the hippocampus of acute immobilization stress rats. Chin. J. Integr. Tradit. West. Med. 2013;33:376\u2013379.", "ArticleIdList": ["23713254"]}, {"Citation": "Dong J., Wang J., Fang J., Feng R., Yuan Z., Lu K., Jin Y., Zeng L. Effects of ginsenosides Rb1 on learning and memory and expression of somatostatin in sleep deprivation rats. J. Zhejiang Univ. 2013;42:197\u2013204.", "ArticleIdList": ["23585007"]}, {"Citation": "Liang J., Yu Y., Wang B., Lu B., Zhang J., Zhang H., Ge P. Ginsenoside Rb1 attenuates oxygen-glucose deprivation-induced apoptosis in SH-SY5Y cells via protection of mitochondria and inhibition of AIF and cytochrome c release. Molecules. 2013;18:12777\u201312792. doi: 10.3390/molecules181012777.", "ArticleIdList": ["10.3390/molecules181012777", "PMC6270437", "24135936"]}, {"Citation": "Wu H.T., Chen X.X., Xiong L.J. Experimental study of proliferation of schwann cells cultured with ginsenoside rb_1. Chin. J. Repar. Reconstr. Surg. 2003;17:26\u201329.", "ArticleIdList": ["12916303"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "12"}, {"Year": "2019", "Month": "8", "Day": "7"}, {"Year": "2019", "Month": "8", "Day": "12"}, {"Year": "2019", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["31416121", "PMC6720911", "10.3390/molecules24162939", "molecules24162939"]}}]}